3.5 mg BORTENAT Bortezomib for Injection

Strength 3.5 mg
Volume Per Vial 10 ml
Route Of Administration intravenous (IV) or subcutaneous (SC)
Packaging Type Vial
Reconstitution Required No
Shelf Life 2 year
Country of Origin Made in India
Manufacturer Natco
Brand Bortenat
Composition Bortezomib For Injection
Packaging Size 1 Injection in 1 vial
Form Injection
Minimum order quantity: 50 Vial

Bortenat 3.5 mg is a prescription-only chemotherapy medication containing Bortezomib. It treats multiple myeloma and mantle cell lymphoma by blocking cell proteins, inducing cancer cell death. Administered via IV or subcutaneous injection by a healthcare professional, it costs roughly ₹1,200 to ₹3,900 per vial in India.

liketo,usa.uk.china.southkorea.russia.japan.singapore